As more and more Americans and people across the globe are administered the COVID-19 vaccine, Global WholeHealth Partners is hopeful that we are continuing in the right direction to get COVID-19 under control. However, we are proud to announce that we are still supplying in demand PPE supplies and COVID-19 diagnostic testing kits in wholesale quantities to interested parties. With the recent distribution and administering of two man vaccines, Pfizer and Moderna, we are hopeful that COVID-19 cases will begin to decline. However, until then, the use of PPE supplies and COVID-19 diagnostic testing remains high and we are committed to offering these in demand products at competitive price points.
Even with the vaccines currently in distribution, it is important to remember that we can help slow the spread of COVID-19 by wearing masks in public spaces, social distancing when we can, and quarantining when we are sick. Masks wearing is required in most public indoor places such as shopping malls, grocery stores and restaurants and often times negative COVID-19 tests are required for travel.
For more information about our available PPE supplies including masks, gloves and thermometers or COVID-19 diagnostic testing kits, contact Global WholeHealth Partners today at 877-568-4947. We can help you place your order for wholesale PPE supplies or wholesale COVID-19 testing kits, or both, depending on your needs. We continue to source and supply these in demand products for our customers across the country. Call 877-568-4947 to start your order now.
About Global WholeHealth Partners OTC (GWHP)
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 - 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.